For example, when the goal is to promote the inclusion of a coding exon, such as the case with SMN2 exon 7 linked to spinal muscular atrophy (SMA), an ideal target must be a negative regulatory element, which is accessible and located within an intron [4]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.